Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New Heat-Based treatment for hemorrhoids could be as effective as standard surgery

NCT ID NCT06170736

Disease control Sponsor: Centre Hospitalier Departemental Vendee Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two minimally invasive procedures for grade II/III hemorrhoids: radiofrequency ablation (using heat) and Doppler-guided artery ligation with mucopexy (tying off blood vessels). The goal is to see if the newer heat-based method is as good as the standard one at reducing symptoms like pain, bleeding, and prolapse. About 168 adults who need surgery for their hemorrhoids will take part, and the main outcome is failure rate one year after treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
radiofrequency ablation or Doppler-guided hemorrhoidal artery ligation with mucopexy
What this could lead to
If successful, this could show that radiofrequency ablation is as effective as the current standard, offering patients a less invasive option with potentially lower recurrence rates.
What could go wrong
This is a relatively small trial (168 participants) and recurrence is still possible with both procedures. The results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 168 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2024

Expected to finish

Sep 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Major patient, * With symptomatic Grade II or III haemorrhoidal disease, * Requiring surgical management, * Patient able to understand the protocol and having given written informed consent to participate in the study, * Patient affiliated to the social security system or entitled to it. Exclusion Criteria: * Hemostasis disorders * Active external haemorrhoidal disease (thrombosis) * History of surgical procedure for treatment of haemorrhoids (instrumental treatment is not a contra-indication) * Associated proctological pathology (anal fissure, chronic suppuration, external rectal prolapse) * History of colorectal cancer * History of inflammatory bowel disease * History of rectal resection * Patient participating in another interventional clinical research protocol involving a drug or clinical investigation of a medical device * Patient who is pregnant, breastfeeding or able to procreate without effective contraception\* at the time of inclusion * Patient under guardianship, curators or deprived of liberty. * Patient under court protection. * oral contraceptive (pill), monthly vaginal ring, weekly transdermal patch, subcutaneous implant, intrauterine devices (IUD), or sterilisation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Grade II/III haemorrhoids are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hemorrhoid internal hemorrhoid

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Grade II/III haemorrhoids Haemorrhoids Internal haemorrhoids

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    18 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU Limoges

    RECRUITING

    Limoges, France

  • Cabinet de Proctologie

    NOT_YET_RECRUITING

    Saint-Herblain, France

  • Centre Hospitalier Départemental de Vendée

    RECRUITING

    La Roche-sur-Yon, France

  • Centre Hospitalier Interrégional

    RECRUITING

    Poissy, France

  • Centre Hospitalier Privé

    RECRUITING

    Brest, France

  • Centre Hospitalier Universitaire

    RECRUITING

    Amiens, France

  • Centre Hospitalier Universitaire

    RECRUITING

    Angers, France

  • Centre Hospitalier Universitaire

    RECRUITING

    Nantes, France

  • Centre Hospitalier Universitaire

    RECRUITING

    Rennes, France

  • Clinique Jules Verne

    RECRUITING

    Nantes, France

  • Clinique de l'Estuaire

    RECRUITING

    Saint-Nazaire, France

  • Clinique de la Sauvegarde

    RECRUITING

    Lyon, France

  • Clinique du val d'Ouest

    RECRUITING

    Écully, France

  • Hôpital Saint Joseph

    RECRUITING

    Paris, France

  • Hôpital de la Louvière

    RECRUITING

    Lille, France

  • Institut Mutualiste Montsouris

    RECRUITING

    Paris, France

  • Maison de Santé Bagatelle

    RECRUITING

    Bordeaux, 33000, France

  • hôpital d'Instruction des Armées

    RECRUITING

    Saint-Mandé, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.